XBI SPDR® S&P Biotech ETF
S&P Biotechnology Select Industry TR USD

NAV as of 16-May-2022

68.4898

4 Week: 62.81 - 84.79

52 Week: 62.81 - 138.68

Latest Closing Price

71.46

Premium / Discount

0.08

Expense Ratio

0.35%

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

Main Fund Characteristics

Fund Manager:
SPDR State Street Global Advisors
Asset Under Management:
5,769,417,867
Launch Date:
30/01/2006
Asset Class:
Equity
Replication Method:
Physical-Sample
Number of Holdings:
158
Trading Currency:
USD
Style:
Small Growth
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-39.383.27-12.03
1 Day-5.020.000.00
1 Week8.069.640.84
1 Month-18.8119.60-0.96
3 Months-24.0727.48-0.88
6 Months-44.4734.51-1.29
1 Year-46.6338.57-1.21
2 Years-35.7751.18-0.70
3 Years-17.7963.71-0.28
5 Years-3.0475.10-0.04
10 Years-13.75149.67-0.09

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 32.857648.505644.668213.6064-15.437243.6993-14.902132.200648.1873-20.5308
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 11.000047.00001.00005.000076.00008.000096.000019.000012.000098.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
15/12/201626/12/20160.0183
16/06/201626/06/20160.0455
18/12/201429/12/20140.4910
18/09/201428/09/20140.5628
19/06/201429/06/20140.6161
20/03/201430/03/20140.3330
19/12/201330/12/20130.0378
19/09/201330/10/20130.0873
20/06/201330/06/20130.0516
14/03/201324/03/20130.0440

Portfolio Data

Total Number of Holdings: 158

Number of Bond Holdings: 0

Number of Equity Holdings: 157

Total Market Value: 5,769,417,867

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Acceleron Pharma Inc1.0324385,782-23,04068,333,566

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant1.18
Large5.88
Medium10.78
Small32.61
Micro49.50

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

12.4941

Price/Book*

2.1531

Price/Sales*

1.7125

Price/Cash Flow*

10.6943

Dividend Yield*

0.1603

Growth Measures

Long-Term Earnings

12.5886

Historical Earnings

9.7112

Sales Growth

17.1711

Cash-Flow Growth

9.5340

Book-Value Growth

3.7137

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.